01 Nov, EOD - Indian

SENSEX 79724.12 (0.42)

Nifty 50 24304.35 (0.41)

Nifty Bank 51673.9 (0.39)

Nifty IT 40433.65 (0.06)

Nifty Midcap 100 56496.05 (0.68)

Nifty Next 50 70400.75 (0.70)

Nifty Pharma 22807.15 (0.31)

Nifty Smallcap 100 18794.9 (1.03)

01 Nov, EOD - Global

NIKKEI 225 38053.67 (-2.63)

HANG SENG 20506.43 (0.93)

S&P 5771.25 (0.36)

LOGIN HERE

Rainbow Childrens Medicare Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 543524 | NSE Symbol : RAINBOW | ISIN : INE961O01016 | Industry : Healthcare |


Chairman's Speech

AS WE CELEBRATE 25 YEARS OF DEDICATED SERVICE AT RAINBOW CHILDREN'S HOSPITAL, OUR COMMITMENT TO CLINICAL EXCELLENCE AND PATIENT-CENTRIC CARE REMAINS STRONGER THAN EVER. OUR JOURNEY, MARKED BY NUMEROUS MILESTONES, REFLECTS OUR UNWAVERING DEDICATION TO SETTING NEW STANDARDS IN PAEDIATRIC HEALTHCARE.

Dear Shareholders,

It is with immense pleasure and gratitude that I acknowledge the 25-year milestone of

Rainbow Children's

Hospital. It has been an extremely satisfying journey that began with a mission to bring specialised paediatric healthcare of international standards to India.

Our journey started in 1999 when we opened our first hospital with

50 beds in Hyderabad, driven by an unwavering commitment to our mission. The effort was marked by a consistent focus on clinical excellence, backward integration into perinatal services to provide comprehensive healthcare for the mother and the child, and compassionate care in a patient-centric environment, which established us as a unique and leading paediatric multi-specialty hospital chain in the Indian healthcare sector. Today, we have 1,935 beds across 19 hospitals and 4 outpatient clinics spread across 6 Indian cities.

I am excited as we embark on the next phase of our journey.

The proven resilience and success of our operating model strengthens our resolve to expand our network across the country.

Clinical Updates

I am delighted to share that two of our hospitals received the prestigious ‘Gold Seal of Quality' from the

Joint Commission International (JCI), affirming our commitment to high standards of patient care. Rainbow Children's Hospital, Banjara Hills, Hyderabad, became the first paediatric hospital in India to receive JCI Accreditation. In April 2024, our flagship hospital at Marathahalli, Bengaluru, was also awarded JCI accreditation. I am also pleased to share that OMR, Sholinganallur

Hospital in Chennai obtained

NABH accreditation within its first year of operation.

We have significantly raised the bar in paediatric critical care by offering air ambulance services, extensive ECMO services, and transplant ICU services. During the year, we retrieved five air transports to our hub hospital in

Hyderabad. One such case involved a critically sick child on High-Frequency Oscillatory Ventilation (HFOV) and nitric oxide therapy, air transported from Goa. This was perhaps the first complex paediatric air transport in India.

Financial Review

FY 2024 was a year of resilient financial performance against a backdrop of seasonal headwinds.

Our operating revenue reached

Rs 12,969 million, marking a 10.5% increase from the previous year.

Our sharp focus on cost management without compromising on clinical outcomes and patient satisfaction, along with improving operational efficiency, helped the Company to maintain healthy financials.

Building Capacity for the Future

During the year, we commissioned 280 beds across three new spoke hospitals, one each in Hyderabad, Bengaluru and Chennai, and also added a new block to cater to demand at the existing hospital at Hydernagar in Hyderabad City. Apart from these hospitals, we opened an outpatient clinic at

Hennur, Bengaluru. This is the first time that we have had such a large capacity commissioned in a short span of time. Our team has meticulously executed on the ground to ensure the timely commissioning of our projects.

Another major highlight was the introduction of IVF services at eight additional hospitals, increasing the total to 11 hospitals that now offer IVF services. This expansion has significantly enhanced our Birthright Services, enabling us to offer a comprehensive suite of women's care offerings under one roof.

Our upcoming hospitals in the southern region, comprising a spoke at Hennur, Bengaluru (~60 beds), regional spoke at Rajahmundry, Andhra Pradesh (~100 beds), and regional spoke at Coimbatore, Tamil Nadu (~100 beds), are in various stages of execution and progressing as planned. We expect to commence operations at Rajahmundry and Hennur Hospitals by the last quarter of FY 2025 and at Coimbatore

Hospital in FY 2026. Furthermore, we are in the design phase for two new hospitals in Gurugram, NCR, with a combined capacity of ~400 beds.

Medical Tourism

India, known for its advanced yet affordable healthcare services, remains a preferred medical destination for many developing countries. We are actively exploring opportunities in medical tourism, supported by a dedicated sales team and direct health cooperation agreements with governments. This year, we formed strategic alliances with the Government of the United Republic of Tanzania and the

Ministry of Health, Zanzibar, to offer comprehensive specialty children healthcare services and also clinical exchange programmes in paediatric healthcare. Looking ahead, led by our focused efforts and presence in cities well-connected to international destinations such as East Africa, Indian neighbourhood and CIS countries, we anticipate a significant influx of overseas patients seeking super specialty paediatric care at our hospitals.

Digital Transformation

We are committed to providing patient-centric care and leading healthcare innovation by embracing digital and technological solutions.

We have transitioned to an advanced

Hospital Information System (HIS) to enhance our backend infrastructure. This new HIS operates on a robust cloud platform, providing scalability and enhanced security. Additionally, we have strengthened our digital healthcare initiatives, including video consultation services, patient portals, and the integration of electronic medical records (EMR) systems to enhance patient experiences.

We have also implemented Salesforce CRM system and deployed cloud technologies to improve sales efficiency and outcomes.

People Capabilities

Our medical professionals play a critical role in achieving our strategic and operational objectives. We take pride in having one of the best healthcare teams and have continued to enhance their expertise to ensure the highest standards of medical care. Additionally, we have onboarded proficient consultants to support the success of our existing and new units and strengthen our ability to deliver superior patient outcomes.

Our high patient satisfaction is also a testament to the dedication and commitment of our staff.

We place significant emphasis on their talent development through structured training and continuous learning opportunities. This year, our recruitment initiatives have successfully attracted talent from diverse industry backgrounds to enhance our expertise and service delivery. We have added leadership teams in Corporate Sales, Projects, Nursing, Learning and Development.

This foundation will help us strengthen our performance across various facets of our operations. In addition, through various initiatives, we have made significant progress in advancing diversity, equity, and inclusion across the organisation.

To steer our strategic direction in the coming years, I am pleased to announce enhancement to the Company's Board. The Board appointed Dr. Adarsh Kancharla, one of our promoters, as a Non-Executive Director. I warmly welcome the new Board member and am confident that his inclusion on the Board will help the Company build a dynamic and youthful organisational culture, significantly contributing to the next phase of our growth journey.

ESG Focus for Sustainable Growth

At Rainbow, we are committed to maintaining high performance across environmental, social, and governance aspects. As part of our efforts to drive energy efficiency, we have established solar rooftops, installed solar water heaters, and adopted Internet of Things (IoT) technology, among other measures. This year, we began sourcing renewable energy from open access systems for multiple units, further minimising our environmental footprint. Our corporate social responsibility initiatives aim to positively impact societal health and well-being.

We remain steadfast in practising the highest levels of governance, professionalism, and transparency to create long-term stakeholder value. In line with regulations and industry standards, we have a robust risk management framework.

Growth Outlook

As we continue to successfully execute our strategic objectives, I am confident in our ability to accelerate growth momentum and capture forthcoming opportunities.

Our multi-faceted approach includes expanding capacity at strategic locations, strengthening IVF services, and prioritising international business expansion, among other initiatives.

Since our public listing, we have commissioned 435 beds, representing 22% of our existing bed capacity, within stipulated timelines.

We remain dedicated to fulfilling our commitment to commission the remaining beds within the guided timelines. Furthermore, as new hospitals mature, they are expected to replicate the performance of our matured hospitals. While pursuing network expansion, our focus remains on adopting a targeted go-to-market approach and exploring new markets through a clinical model to assess feasibility and potential.

Given our robust balance sheet and strong cash flows, along with anticipated internal accruals in the coming years, we are confident in our ability to fund all planned capital expenditures internally without requiring debt financing. Being system-driven and predominantly operating asset-light hospitals enhances our potential to drive sustained stakeholder growth. Additionally, we remain open to actively exploring mergers and acquisitions (M&A) opportunities.

Acknowledgements

I extend my heartfelt gratitude to our valued stakeholders, esteemed Board Members, proficient doctors, dedicated employees, visionary management team, and everyone else who has contributed to making Rainbow what it is today. Even as I reflect on Rainbow's successful journey with pride, I firmly believe that the future holds even greater promise. With renewed commitment to our mission of delivering excellent multi-disciplinary paediatric and perinatal care services, with the ultimate goal of contributing towards a healthier nation, we are poised to usher a stronger and a sustainable future.

Thank You. Warm regards,

Dr. Ramesh Kancharla

Chairman and Managing Director